SEC Form 4 · accession 0001093557-18-000116
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark G Foletta
Director
Period of report
May 31, 2018
Accepted (ET)
Jun 4, 2018 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | May 31, 2018 | A | 4,062 | $0.001 | A | 9,014 | D | |
| Common StockF4 | holding | — | — | — | 13,143 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. commom stock upon settlement.
- F2The RSU Award was granted on May 31, 2018 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting.
- F3Represents 9,014 restricted stock units, 4,952 of which were granted on June 1, 2017 and shall vest on June 1, 2018 and 4,062 of which were granted on May 31, 2018 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting.
- F4Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.